Vasella signs final deal with Novartis
This article was originally published in Scrip
Executive Summary
Novartis has signed a final deal with its former chairman Daniel Vasella which will see him receive CHF2.7m ($2.9m) in cash, CHF2.2m in shares and a flexible consulting contract which will guarantee him $750k by the end of 2016.